These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38353954)

  • 21. Perceived discrimination is associated with reduced breast and cervical cancer screening: the Study of Women's Health Across the Nation (SWAN).
    Jacobs EA; Rathouz PJ; Karavolos K; Everson-Rose SA; Janssen I; Kravitz HM; Lewis TT; Powell LH
    J Womens Health (Larchmt); 2014 Feb; 23(2):138-45. PubMed ID: 24261647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance Mammography Behaviors in Black and White Breast Cancer Survivors: Behavioral Risk Factors and Surveillance System, 2016.
    Edmonds MC; Dahman B; Kim SJ; McGuire KP; Sheppard VB
    BMC Womens Health; 2023 Mar; 23(1):148. PubMed ID: 36997881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001-14: a case only analysis.
    Dos-Santos-Silva I; De Stavola BL; Renna NL; Nogueira MC; Aquino EML; Bustamante-Teixeira MT; Azevedo E Silva G
    Lancet Glob Health; 2019 Jun; 7(6):e784-e797. PubMed ID: 31097280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient Cost-Sharing and Utilization of Breast Cancer Diagnostic Imaging by Patients Undergoing Subsequent Testing After a Screening Mammogram.
    Hughes DR; Espinoza W; Fein S; Rula EY; McGinty G
    JAMA Netw Open; 2023 Mar; 6(3):e234893. PubMed ID: 36972047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity.
    Lawson MB; Bissell MCS; Miglioretti DL; Eavey J; Chapman CH; Mandelblatt JS; Onega T; Henderson LM; Rauscher GH; Kerlikowske K; Sprague BL; Bowles EJA; Gard CC; Parsian S; Lee CI
    JAMA Oncol; 2022 Aug; 8(8):1115-1126. PubMed ID: 35737381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts.
    Ezratty C; Vang S; Brown J; Margolies LR; Jandorf L; Lin JJ
    Breast Cancer Res Treat; 2020 Jul; 182(1):181-185. PubMed ID: 32394349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Social Determinants of Health in Self-Reported Access to Health Care Among Women Undergoing Screening Mammography.
    Henderson LM; O'Meara ES; Haas JS; Lee CI; Kerlikowske K; Sprague BL; Alford-Teaster J; Onega T
    J Womens Health (Larchmt); 2020 Nov; 29(11):1437-1446. PubMed ID: 32366199
    [No Abstract]   [Full Text] [Related]  

  • 30. Mammography use, breast cancer stage at diagnosis, and survival among older women.
    McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
    J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and evaluation of a decision aid on mammography screening for women 75 years and older.
    Schonberg MA; Hamel MB; Davis RB; Griggs MC; Wee CC; Fagerlin A; Marcantonio ER
    JAMA Intern Med; 2014 Mar; 174(3):417-24. PubMed ID: 24378846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated with Adherence to Routine Screening Mammography in HIV-Infected Women.
    Weinstein ZM; Battaglia TA; Baranoski AS
    J Womens Health (Larchmt); 2016 May; 25(5):473-9. PubMed ID: 27168388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients.
    Lim ZL; Ho PJ; Khng AJ; Yeoh YS; Ong ATW; Tan BKT; Tan EY; Tan SM; Lim GH; Lee JA; Tan VK; Hu J; Li J; Hartman M
    BMC Med; 2022 Aug; 20(1):239. PubMed ID: 35922814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
    Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
    Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States).
    Norman SA; Localio AR; Zhou L; Weber AL; Coates RJ; Malone KE; Bernstein L; Marchbanks PA; Liff JM; Lee NC; Nadel MR
    Cancer Causes Control; 2006 Sep; 17(7):921-9. PubMed ID: 16841259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammography capacity impact on screening rates and breast cancer stage at diagnosis.
    Elting LS; Cooksley CD; Bekele BN; Giordano SH; Shih YC; Lovell KK; Avritscher EB; Theriault R
    Am J Prev Med; 2009 Aug; 37(2):102-8. PubMed ID: 19524392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammography screening matters for young women with breast carcinoma: evidence of downstaging among 42-49-year-old women with a history of previous mammography screening.
    Buseman S; Mouchawar J; Calonge N; Byers T
    Cancer; 2003 Jan; 97(2):352-8. PubMed ID: 12518359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.
    Houssami N; Abraham LA; Miglioretti DL; Sickles EA; Kerlikowske K; Buist DS; Geller BM; Muss HB; Irwig L
    JAMA; 2011 Feb; 305(8):790-9. PubMed ID: 21343578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
    Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
    Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.